The objective of this study was to determine the antibiotic susceptibility of Arcobacter spp. isolated from various sources. Seventy Arcobacter spp. isolates were tested for their susceptibility to 13 antimicrobial agents. Antimicrobial susceptibility testing was performed by using the agar disc diffusion method on Mueller-Hinton agar supplemented with 5% defibrinated sheep blood. The antibiotics tested included enrofloxacin, erythromycin, streptomycin, gentamycin, rifampin, tetracycline, ampicillin, trimethoprim/ sulfamethoxazole, nalidixic acid, danofloxacin, amoxycillin-clavulonic acid, cefuroxime-sodium, neomycine. Although all the arcobacters tested were susceptible to gentamycin, resistance to three or more antibacterial agents (especially, trimethoprim/sulfamethoxazole, cefuroxime-sodium and rifampin) was observed. A. butzleri isolates were found to be resistant to amoxycillin+clavulonic acid, nalidixic acid and ampicillin, at the rate of 20%, 44.28% and 78.57% respectively. In conclusion, gentamycin, streptomycin and tetracycline may be suitable antibiotics for the treatment or control of disease caused by Arcobacter spp. in veterinary and human medicine. KEY WORDS: agar disc diffusion, antibacterial susceptibility, Arcobacter spp.
The genus Arcobacter, previously known as "aerotolerant campylobacters", is Gram negative, non-spore-forming, motile and spiral shaped rods. Arcobacters were first isolated from aborted bovine fetuses [6] . They can grow microaerobically and aerobically and have the ability to grow from 15 to 37°c. The distinctive features of arcobacters from the Campylobacter species are growth at 15°c and aerotolerance [24] . So far, thirteen species have been identified from different sources within the genus Arcobacter: Arcobacter butzleri, A. cryaerophilus(subgroups 1A and 1B), A. skirrowii, A. nitrofigilis, A. cibarius, A. halophilus A. mytili, A. thereius, A. marinus, A. trophiarum, A. defluvii, A. molluscorum and A. ellisii [5, 10] . Among these species A. butzleri, A. cryaerophilus and A. skirrowii have been associated with enteritis and, occasionally, bacteremia in humans [17] and abortion and mastitis in cattle and swine [6, 18, 22] . However, Arcobacter has been isolated from large numbers of clinically healthy animals [2, 20, 26, 27] and various environmental sources such as water and sludge [4, 7] .
Several studies have been conducted to determine the antibacterial susceptibility of arcobacters isolated from environmental [8, 21] , animal [1, 21, 23] and human [9, 15, 25] , origin. However, it is known that reports on the antimicrobial resistance of Arcobacter strains from different sources are limited worldwide.
The aim of this study was to assess the antibacterial susceptibility of Arcobacter spp. isolated from different sources including chicken carcass, minced beef, quail carcass, turkey meat, cattle rectal swabs, cattle gallbladder, broiler cloacal swab, cattle rectal swabs and human clinical cases. Also, the antibiotics used in our study are of utmost importance in veterinary and human medicine for the treatment and control of bacterial infections.
MATERIALS AND METHODS
Arcobacter spp. Isolates: Seventy Arcobacter spp. isolates were tested for their susceptibility to 13 antimicrobial agents. A. butzleri strains were isolated from chicken carcasses (31), minced beef (11), quail carcass (4), turkey meat (2), cattle rectal swabs (7) , cattle gallbladder (2), broiler cloacal swab (1), and human gastroenteritis cases (12) . While the human clinical strains were isolated from acute gastroenteritis cases between 2006 and 2010 by using the direct plating method onto cAT agar (mccD agar with CAT supplement -Oxoid CM0689, Oxoid SR174, England), the animal isolates were obtained from the culture collection in the Microbiology Department of the Veterinary Faculty, at Erciyes University in Kayseri, Turkey by using the enrichment method in Arcobacter Enrichment Broth [2] .
All Arcobacter isolates used in this study were identified at genus and species level using genus specific PCR [11] and multiplex-PCR [13] respectively.
A reference strain of A. butzleri LMG 10828 (LMG Bacterial collection, Ghent University, Ghent, Belgium) was included as positive control throughout the study.
Antibacterial susceptibility testing: Antimicrobial agents used. The following antibiotic discs were used: amoxycillinclavulonic acid (AMc, 30 µg), ampicillin (AMP, 10 µg), cefuroxime-sodium (CXM, 30 µg), danofloxacin (DFX, 5 µg), enrofloxacin (ENR, 5 µg), erythromycin (E, 15 µg), gentamycin (cN, 10 µg), nalidixic acid (NA, 30 µg), neomycine (N, 10 µg), rifampin (RD, 5 µg), streptomycin (S, 10 µg), tetracycline (TE, 30 µg), and trimethoprim/sulfamethoxazole (SXT, 23.7 µg-1.25 µg). The antimicrobial discs were purchased from Oxoid (UK) except for enrofloxacin and danofloxacin, which were obtained from Bayer (Germany).
Determination of antimicrobial sensitivity: An antimicrobial susceptibility test was carried out using the disc diffusion method described previously [3] . In brief, the isolates were grown on blood agar at 37°c under microaerobic conditions with a gas generating kit (Anaerocult c, Merck, Germany) for 48 hr. After that, a suspension of each organism adjusted to McFarland 0.5 was made in physiological saline. The suspensions were spread onto Muller Hinton Agar (Merck, 1.05437, Germany) supplemented with 5% defibrinated sheep blood and then each antibiotic disc was placed onto the agar. The plates were incubated at 37°c under microaerobic atmosphere as described above. After a 48 hr incubation period, the diameter of the inhibition zones was measured with callipers and the results were interpreted by adopting the manufacturer's directions for most other pathogenic bacteria.
RESULTS
In the present study the results of the antibacterial susceptibility testing for seventy Arcobacter butzleri strains isolated from different sources are shown in Table 1 .
All Arcobacter isolates were susceptible to cN and resistant to SXT, CXM and RD. A. butzleri strains were resistant to AMC, NA, E, DFX, ENR, AMP, TE, N and S at the rate of 20%, 44.28%, 14.28%, 14.28%, 12.85%, 78.57%, 2.85%, 4.28% and 2.85% respectively and showed an intermediate level of resistance to the same antibacterial agents at the rate of 32.85%, 37.14%, 80%, 25.71%, 20%, 4.28%, 27.14%, 57.14% and 8.57% respectively. Also A. butzleri strains were found to be susceptible to TE and S at the rate of 70%, 88.57% respectively.
Multidrug resistances: The multiple resistance of arcobacters was observed in this study. All of the A. butzleri isolates were resistant to three or more antibacterial agents ( Table 2 ). The majority of A. butzleri strains were resistant to four antimicrobials (SXT, RD, CXM, AMP) at the rate of 32.85% (23/70). Resistance to five antimicrobials including SXT, RD, CXM, AMP, NA for A. butzleri was found at a rate of 14.28% (10/70). Also resistance to six antimicrobials including SXT, RD, CXM, AMP, NA, AMC was found at a rate of 11.42% (8/70).
DIScUSSION
The antimicrobial resistance patterns of Arcobacter spp. isolated from different sources were evaluated in this study. There are relatively few reports on antimicrobial susceptibilities conducted on arcobacters [8, 14, 21, 23] . Furthermore, there are no internationally accepted criteria for susceptibility testing and breakpoint evaluation for Arcobacter spp. [1, 23] . The criteria used to categorize the isolates as resistant, susceptible and intermediate were adopted from those recommended by the manufacturers for the most common bacterial pathogens. The results of antimicrobial disc diffusion testing are presented in Table  1 (A. butzleri isolates). In our research, arcobacters were found to be susceptible to the aminoglycosides, gentamycin and streptomycin. This is in agreement with the findings of other authors [1, 21, 23] . They reported that the majority of Arcobacter strains in their studies were susceptible to gentamycin and tobramycin. In addition one previous study [8] reported that arcobacters were susceptible to gentamycin and tobramycin whilst amikacin was the most active aminoglycoside.
On the other hand, we found that all A. butzleri strains were resistant to cefuroxime sodium and trimetophrimsulphamethoxazole. These results are similar to those of Atabay and Aydin [1] . Moreover, Kabeya et al. [16] declared high levels of resistance to trimetophrim-sulphamethoxazole (67.2%) in arcobacters. Different results about quinolone resistances in arcobacters were reported by some researchers [1, 8, 25] . Atabay and Aydin [1] reported that their strains were susceptible to DFX and ENR. Fera et al. [8] indicated that fluoroquinolones were effective against A. butzleri and A. cryaerophilus isolates. Vandenberg et al. [25] , found that most A. butzleri isolates were susceptible to ciprofloxacin (96.7%). In contrast, A. butzleri isolates in our research were found to be resistant to ENR and DFX at the rate of 12.85% and 14.28% respectively. These results may be attributed to the origins of the isolates and geographic distribution of arcobacters [19] .
We found that 44.28% of the A.butzleri isolates tested were resistant to nalidixic acid similar to the results (63.5%) of Kabeya et al. [16] , and contrary to those of Atabay and Aydin [1] who reported that all strains of A.butzleri were susceptible to nalidixic acid. Quinolone resistance detected in arcobacters in our study may be related to the use of this antibacterial agent in veterinary practice as growth promoters or as a therapeutic drug.
Erythromycin is the drug of choice for treatment of human campylobacteriosis. In our study, 25% and 66.66% of human A. butzleri isolates were found to be resistant and have intermediate levels of susceptibility to erythromycin respectively. Similar resistance findings for human arcobacters to erythromycin were reported by some authors [15, 25] . In addition other authors [1, 16, 23] have reported that arcobacters isolated from chicken carcasses were susceptible to erythromycin. On the contrary, in this study 14.28% and 80% of the A. butzleri isolates from different sources were found to be resistant and show intermediate susceptibility levels to erythromycin respectively.
Son et al. [23] also reported that all A. butzleri strains isolated from broiler carcasses were susceptible to tetracycline and they indicated that tetracycline might be useful for the treatment of Arcobacter infections in human and veterinary medicine. Similarly, in our research A. butzleri isolates were found to be susceptible to tetracycline at the rate of 70%. In contrast, Harras et al. [12] suggested that a high proportion of A. butzleri strains were resistant to tetracycline.
While Arcobacter isolates were found to be susceptible to ampicillin according to some authors [1, 16] , the high percentages of resistant arcobacters to ampicillin reported by others [8, 25] were compatible with our study (78.57%).
Multidrug resistance was observed against antibacterial agents between three and nine ( Table 2 ). The predominant resistance pattern for arcobacters tested in our study was SXT, RD, CXM and AMP. In arcobacters, multidrug resistance was shown to 2 or 4 antibacterials including nalidixic acid, chloramphenicol, cephalotine, trimethoprim-sulphamethaxole, ciprofloxacin, tetracycline and erythromycin by authors [16, 23] . Most of the human A. butzleri strains obtained from human clinical cases associated with gastroenteritis had resistances to four or more antibacterial agents. For this reason the antibacterial susceptibility results of these isolates are important for treatment options in human medicine. Similar results regarding multidrug resistance in this study were detected in poultry isolates. considering that Arcobacter species are commonly isolated from various sources, especially poultry carcasses [2, 7] . It might therefore be possible that the source of the infection could be chicken meat. In conclusion, gentamycin, streptomycin and tetracycline may be suitable antibiotics for the treatment or control of disease caused by Arcobacter spp. in veterinary and human medicine.
